Consonance Capital Management’s Medicus Sciences Acquisition Corp. Unit MSACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-300,000
Closed -$2.96M 42
2021
Q1
$2.96M Buy
+300,000
New +$3.05M 0.32% 31

Other funds holding MSACU

Consonance Capital Management's MSACU Position: Q2 2021 in Review

Consonance Capital Management sold out of Medicus Sciences Acquisition Corp. Unit (MSACU) in Q2 2021, closing a stake of 300,000 shares — an estimated $2.96M sold.

Consonance Capital Management first reported a position in MSACU in Q1 2021 and held it in 1 quarter. The position peaked at $2.96M in Q1 2021. 1 fund tracked by Wall St. Rank holds MSACU as of Q2 2021.

  • Consonance Capital Management reported no remaining Medicus Sciences Acquisition Corp. Unit position as of Q2 2021 after selling out during the quarter.
  • Consonance Capital Management sold 300,000 Medicus Sciences Acquisition Corp. Unit shares in Q2 2021, an estimated $2.96M.
  • Consonance Capital Management first reported a position in Medicus Sciences Acquisition Corp. Unit in Q1 2021 and held it in 1 quarter.
  • Consonance Capital Management's Medicus Sciences Acquisition Corp. Unit position peaked at $2.96M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Unit as of Q2 2021.

Based on Consonance Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.